Annual EBIT
-$132.55 M
-$72.65 M-121.30%
31 December 2023
Summary:
Tarsus Pharmaceuticals annual earnings before interest & taxes is currently -$132.55 million, with the most recent change of -$72.65 million (-121.30%) on 31 December 2023. During the last 3 years, it has fallen by -$105.55 million (-390.95%). TARS annual EBIT is now -9718.30% below its all-time high of -$1.35 million.TARS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$21.10 M
+$10.18 M+32.54%
30 September 2024
Summary:
Tarsus Pharmaceuticals quarterly earnings before interest & taxes is currently -$21.10 million, with the most recent change of +$10.18 million (+32.54%) on 30 September 2024. Over the past year, it has increased by +$17.22 million (+44.93%). TARS quarterly EBIT is now -296.98% below its all-time high of $10.71 million, reached on 31 March 2021.TARS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$128.11 M
+$17.22 M+11.85%
30 September 2024
Summary:
Tarsus Pharmaceuticals TTM earnings before interest & taxes is currently -$128.11 million, with the most recent change of +$17.22 million (+11.85%) on 30 September 2024. Over the past year, it has dropped by -$23.45 million (-22.41%). TARS TTM EBIT is now -20138.86% below its all-time high of -$633.00 thousand, reached on 30 September 2019.TARS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -121.3% | +44.9% | -22.4% |
| 3 y3 years | -390.9% | -31.6% | -1245.9% |
| 5 y5 years | -9718.3% | -3234.0% | -10000.0% |
TARS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -862.4% | at low | -305.9% | +48.5% | -1245.9% | +11.8% |
| 5 y | 5 years | -9718.3% | at low | -297.0% | +48.5% | <-9999.0% | +11.8% |
| alltime | all time | -9718.3% | at low | -297.0% | +48.5% | <-9999.0% | +11.8% |
Tarsus Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.10 M(-32.5%) | -$128.11 M(-11.8%) |
| June 2024 | - | -$31.28 M(-10.1%) | -$145.33 M(+0.4%) |
| Mar 2024 | - | -$34.78 M(-15.0%) | -$144.69 M(+9.1%) |
| Dec 2023 | -$132.55 M(+121.3%) | -$40.94 M(+6.8%) | -$132.67 M(+26.8%) |
| Sept 2023 | - | -$38.32 M(+25.1%) | -$104.66 M(+18.6%) |
| June 2023 | - | -$30.64 M(+34.6%) | -$88.27 M(+40.5%) |
| Mar 2023 | - | -$22.76 M(+76.0%) | -$62.83 M(+4.7%) |
| Dec 2022 | -$59.90 M(+334.9%) | -$12.94 M(-41.0%) | -$59.99 M(-3.0%) |
| Sept 2022 | - | -$21.93 M(+321.8%) | -$61.85 M(+10.5%) |
| June 2022 | - | -$5.20 M(-73.9%) | -$55.95 M(+28.7%) |
| Mar 2022 | - | -$19.92 M(+34.6%) | -$43.47 M(+238.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$13.77 M(-49.0%) | -$14.80 M(-7.7%) | -$12.84 M(+34.9%) |
| Sept 2021 | - | -$16.04 M(-320.2%) | -$9.52 M(+162.8%) |
| June 2021 | - | $7.28 M(-32.0%) | -$3.62 M(-74.4%) |
| Mar 2021 | - | $10.71 M(-193.4%) | -$14.17 M(-47.5%) |
| Dec 2020 | -$27.00 M(+528.2%) | -$11.48 M(+13.2%) | -$27.00 M(+62.6%) |
| Sept 2020 | - | -$10.14 M(+210.8%) | -$16.61 M(+134.0%) |
| June 2020 | - | -$3.26 M(+54.1%) | -$7.10 M(+85.1%) |
| Mar 2020 | - | -$2.12 M(+95.4%) | -$3.83 M(+123.4%) |
| Dec 2019 | -$4.30 M(+218.4%) | -$1.08 M(+71.2%) | -$1.72 M(+171.2%) |
| Sept 2019 | - | -$633.00 K | -$633.00 K |
| Dec 2018 | -$1.35 M | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual EBIT year-on-year change?
- What is Tarsus Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly EBIT year-on-year change?
- What is Tarsus Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM EBIT year-on-year change?
What is Tarsus Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of TARS is -$132.55 M
What is the all time high annual EBIT for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual earnings before interest & taxes is -$1.35 M
What is Tarsus Pharmaceuticals annual EBIT year-on-year change?
Over the past year, TARS annual earnings before interest & taxes has changed by -$72.65 M (-121.30%)
What is Tarsus Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of TARS is -$21.10 M
What is the all time high quarterly EBIT for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly earnings before interest & taxes is $10.71 M
What is Tarsus Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, TARS quarterly earnings before interest & taxes has changed by +$17.22 M (+44.93%)
What is Tarsus Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of TARS is -$128.11 M
What is the all time high TTM EBIT for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM earnings before interest & taxes is -$633.00 K
What is Tarsus Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, TARS TTM earnings before interest & taxes has changed by -$23.45 M (-22.41%)